For healthcare professionals
Treating Dry Eye flare effectively can positively impact patient lives in a number of ways; improving clinical signs and symptoms such as dryness, irritation, blurred vision, sore or fatigued eyes, and watering8.
Softacort® (0.335% hydrocortisone sodium phosphate), indicated for mild non-infectious conjunctival inflammation, effectively reduces signs and symptoms of Dry Eye Flare6 with no significant effect on IOP. The SPC can be accessed here.
Learn more about the use of this therapeutic approach in the real world: